---
figid: PMC9467784__JO2022-4257359.002
figtitle: 'Targeting Strategies for Aberrant Lipid Metabolism Reprogramming and the
  Immune Microenvironment in Esophageal Cancer: A Review'
organisms:
- Nicotiana tabacum
- Candida dubliniensis
- Homo sapiens
- Mus musculus
- Helicobacter pylori
organisms_ner:
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC9467784
filename: JO2022-4257359.002.jpg
figlink: /pmc/articles/PMC9467784/figure/fig2/
number: F2
caption: Targeting signaling pathways in EC. Schematic representation of the Wnt,
  Notch, AMPK, MAPK, and Hippo pathways in EC. Novel therapeutics (synthetic and natural)
  kill EC by targeting these signaling pathways or their components. GSK3β, glycogen
  synthase kinase 3β; DSH, Disheveled; APC, adenomatous polyposis coli; GGPP, geranylgeranyl
  pyrophosphate; YAP/TAZ, Yes-associated protein (YAP)/tafazzin (TAZ); JAK/STAT3,
  Janus kinase/signal transducers and activators of transcription 3; SIRT1, silencing
  information regulator 2-related enzyme 1 (sirtuin 1); HNF4A, hepatocyte nuclear
  factor 4 alpha; PGC1A, peroxisome proliferator-activated receptor gamma coactivator
  1-alpha; PPAR-γ, peroxisome proliferator-activated receptor-γ; PI3K-Akt-mTOR pathway,
  the phosphatidylinositol 3-kinase (PI3K)-serine-threonine kinase (Akt)-mammalian
  target of rapamycin (mTOR) pathway; p38 MAPK, p38 mitogen-activated protein kinase;
  pre-SREBP, premature sterol regulatory element-binding protein; M-SREBP, mature
  sterol regulatory element-binding protein.
papertitle: 'Targeting Strategies for Aberrant Lipid Metabolism Reprogramming and
  the Immune Microenvironment in Esophageal Cancer: A Review.'
reftext: Meng-Ying Cui, et al. J Oncol. 2022;2022:4257359.
year: '2022'
doi: 10.1155/2022/4257359
journal_title: Journal of Oncology
journal_nlm_ta: J Oncol
publisher_name: Hindawi
keywords: ''
automl_pathway: 0.961759
figid_alias: PMC9467784__F2
figtype: Figure
redirect_from: /figures/PMC9467784__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9467784__JO2022-4257359.002.html
  '@type': Dataset
  description: Targeting signaling pathways in EC. Schematic representation of the
    Wnt, Notch, AMPK, MAPK, and Hippo pathways in EC. Novel therapeutics (synthetic
    and natural) kill EC by targeting these signaling pathways or their components.
    GSK3β, glycogen synthase kinase 3β; DSH, Disheveled; APC, adenomatous polyposis
    coli; GGPP, geranylgeranyl pyrophosphate; YAP/TAZ, Yes-associated protein (YAP)/tafazzin
    (TAZ); JAK/STAT3, Janus kinase/signal transducers and activators of transcription
    3; SIRT1, silencing information regulator 2-related enzyme 1 (sirtuin 1); HNF4A,
    hepatocyte nuclear factor 4 alpha; PGC1A, peroxisome proliferator-activated receptor
    gamma coactivator 1-alpha; PPAR-γ, peroxisome proliferator-activated receptor-γ;
    PI3K-Akt-mTOR pathway, the phosphatidylinositol 3-kinase (PI3K)-serine-threonine
    kinase (Akt)-mammalian target of rapamycin (mTOR) pathway; p38 MAPK, p38 mitogen-activated
    protein kinase; pre-SREBP, premature sterol regulatory element-binding protein;
    M-SREBP, mature sterol regulatory element-binding protein.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MTOR
  - GOLGA4
  - GSK3A
  - GSK3B
  - STAT3
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - NFKB1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - FASN
  - C3
  - ACSS2
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - IFT81
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - APC
  - PROC
  - YAP1
  - TAFAZZIN
  - WWTR1
  - AXIN1
  - AXIN2
  - EP300
  - PPARGC1A
  - EGFR
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - TLR4
  - CHPT1
  - DHDDS
  - Akt1
  - Pik3r1
  - Mtor
  - Gsk3b
  - Stat3
  - H2-Aa
  - Nfkb1
  - Sall3
  - Fasn
  - Acss2
  - Dvl1
  - Apc
  - Yap1
  - Tafazzin
  - Wwtr1
  - Axin1
  - Ep300
  - Ppargc1a
  - Egfr
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Tlr4
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Tor
  - SREBP
  - sgg
  - Tie
  - Ras85D
  - InR
  - Crtc
  - hop
  - bsk
  - aa
  - Dif
  - dl
  - Rel
  - salt
  - SNF4Agamma
  - AMPKalpha
  - .na.character
  - FASN1
  - FASN2
  - hpo
  - hp
  - wat
  - dsh
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - Apc2
  - Axn
  - Fs(3)Apc
  - yki
  - Taz
  - Dis3
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - srl
  - MKP-4
  - p38b
  - rl
  - lic
  - Nurf-38
  - Ebp
  - p38a
  - Hrb87F
  - p38c
  - Toll-4
  - Cpt
  - CG7149
  - CPT2
---
